Kyle W. Anderson is the Project Leader for H/D exchange mass spectrometry (HDX-MS) for biopharmaceutical analysis at NIST. He is also an Associate Research Professor at the Institute for Bioscience and Biotechnology Research (IBBR), a joint institute of the University of Maryland and NIST. In addition to using hydrogen/deuterium exchange mass spectrometry (HDX-MS) to characterize the structural dynamics of biopharmaceuticals, he is active in developing and promoting adoption of state-of-the-art methods, instrumentation, and software for HDX-MS to ensure quality and accelerate development of biotherapeutics and biosimilars.
Research Objectives:
Postdoctoral Research Opportunities
National Research Council Postdoctoral Research Associate Program at NIST: Rolling application deadlines are Feb 1 and Aug 1. US citizens only. $82,764 (2024) annual salary plus benefits. Contact Kyle Anderson before applying. View Job Posting
Positions for non-US citizens: Contact Kyle Anderson directly.
Committees & Activities :
Editorial Advisory Board, Journal of the American Society for Mass Spectrometry (2024-present)
CIPM CCQM Protein Analysis Working Group member (2023-present)
American Society for Mass Spec. Membership, Diversity, and Inclusion Committee (2024-present)
Washington Chromatography Discussion Group, President (2017–2020, 2021–2022), VP (2016-2017), Secretary (2015–2016, 2020–2021), Board (2022–2023)
NIIMBL Subject Matter Expert
American Society for Mass Spectrometry (2017-present)
CASSS D.C. Area Discussion Group (2015-present)
International Society for HDX-MS (2019 – present)
Washington-Baltimore Mass Spectrometry Discussion Group (2016-present)
U.S. Department of Commerce Silver Medal, 2021
U.S. Department of Commerce Bronze Medal, 2023
ASMS Emerging Investigator, 2023
NIST MML Outreach Accolade, 2019
National Research Council Postdoctoral Research Associateship, 2015